Has Fadi Khoury, MD received payments from drug or device companies?

Yes. Drug and device makers reported $42,458 in general payments to Fadi Khoury, MD across 387 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fadi Khoury, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fadi Khoury, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fadi Khoury, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Mesa, AZNPI 1558708487

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (38.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Atricure, Inc. at 31.9% of the total. 2025 is the largest year on record at $14,130, 2.3 times the $6,022 reported in 2019.

$42,458in general payments, 2019–2025

Across 387 payments — averaging $109.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$14K
Edwards Lifesciences$7K
Endologix LLC$5K
Cvrx, Inc.$3K
W. L. Gore & Associates, Inc.$2K
Medtronic$2K
plus $9K from 27 others

What the payments were for

Consulting fees$10,23524%
Travel & lodging$15,87637%
Food & beverage$16,32938%
Education$170%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	82	$13,543
Edwards Lifesciences	47	$7,312
Endologix LLC	56	$5,123
Cvrx, Inc.	8	$3,424
W. L. Gore & Associates, Inc.	17	$2,302
Medtronic(2 entities)	37	$2,196
Artivion, Inc.	11	$1,997
Abbott	28	$1,838
Abiomed	20	$1,256
Silk Road Medical, Inc.	10	$1,173
Bolton Medical Inc	9	$462
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	14	$272
Penumbra, Inc.	1	$239
Chiesi USA, Inc.	9	$199
Philips North America LLC	2	$193
Getinge USA Sales, LLC	3	$142
Johnson & Johnson(2 entities)	6	$120
Zimmer Biomet	3	$102
Biom'up France SAS	1	$97
Baxter Healthcare	3	$91
Grifols USA, LLC	2	$47
Haemonetics Corporation	2	$44
AstraZeneca	2	$43
Amarin Pharma, Inc.	2	$41
Cook Medical LLC	2	$37
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)	2	$31
Kls-martin L.p.	2	$25
BD	1	$22
Boston Scientific	1	$22
Bayer	1	$19
Stryker	1	$17
E.r. Squibb & Sons, L.L.C.	1	$14
Smith+Nephew	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$5,157
SYNERGY ABLATION SYSTEM$3,927
Barostim Neo System$3,385
AFX2 Bifurcated Endograft System$1,800
Alto Abdominal Stent Graft System$1,536
SAPIEN 3 Ultra RESILIA$1,390
MITRIS RESILIA Mitral Valve$1,292
Epic$1,246
GORE TAG Thoracic Endoprosthesis$1,166
ATRICLIP LAA EXCLUSION SYSTEM$1,130
EPI-SENSE GUIDED COAGULATION SYS$1,110
On-X$1,108
ENROUTE Transcarotid Neuroprotection System$1,013
ENROUTE Transcarotid Stent System$1,013
ENHANCE Transcarotid Peripheral Access Kit$1,013
ENROUTE 0.014 Guidewire$1,013
Impella$990
AMDS-Ascyrus Medical$831
Avalus$815
ATRICURE SYNERGY ABLATION SYSTEM$696

How this compares

$42,458 in reported general payments places this provider in the 80th percentile of 100 thoracic surgery (cardiothoracic vascular surgery) providers in Arizona.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Arizona →

Medicare billing

Part B allowed, 2024

$208,334

Medicare patients

230

Services billed

476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Enoxaparin Sodium	20	$216
ClopidogrelClopidogrel Bisulfate	14	$114
Ciprofloxacin Hcl	11	$71

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Mesa

Hani ShennibMesa$47K
Daniel EadsMesa$15K
Darryl SteinMesa$8K
Emily RapstineMesa$6K
Dawn JaroszewskiPhoenix$794K
Brian DeguzmanScottsdale$630K
Lishan AklogPhoenix$531K
Chirag PatelScottsdale$293K
Abdul Samad HashimiPhoenix$175K
Hao FangPhoenix$171K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →